These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30108977)

  • 1. Inhibition of
    Zhang H; Tomašič T; Shi J; Weiss M; Ruijtenbeek R; Anderluh M; Pieters RJ
    Medchemcomm; 2018 May; 9(5):883-887. PubMed ID: 30108977
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
    Makwana V; Ryan P; Malde AK; Anoopkumar-Dukie S; Rudrawar S
    ChemMedChem; 2021 Feb; 16(3):477-483. PubMed ID: 32991074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate specificity provides insights into the sugar donor recognition mechanism of O-GlcNAc transferase (OGT).
    Ma X; Liu P; Yan H; Sun H; Liu X; Zhou F; Li L; Chen Y; Muthana MM; Chen X; Wang PG; Zhang L
    PLoS One; 2013; 8(5):e63452. PubMed ID: 23700425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.
    Ryan P; Shi Y; von Itzstein M; Rudrawar S
    Bioorg Chem; 2021 May; 110():104738. PubMed ID: 33667901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
    Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
    J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Quinolinone O-GlcNAc Transferase Inhibitors Based on Fragment Growth.
    Weiss M; Loi EM; Sterle M; Balsollier C; Tomašič T; Pieters RJ; Gobec M; Anderluh M
    Front Chem; 2021; 9():666122. PubMed ID: 33937202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate and product analogues as human O-GlcNAc transferase inhibitors.
    Dorfmueller HC; Borodkin VS; Blair DE; Pathak S; Navratilova I; van Aalten DM
    Amino Acids; 2011 Mar; 40(3):781-92. PubMed ID: 20640461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
    Qi J; Wang R; Zeng Y; Yu W; Gu Y
    Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revealing the conformational dynamics of UDP-GlcNAc recognition by O-GlcNAc transferase via Markov state model.
    Tian J; Dong X; Wu T; Wen P; Liu X; Zhang M; An X; Shi D
    Int J Biol Macromol; 2024 Jan; 256(Pt 1):128405. PubMed ID: 38016609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic Promiscuity of O-GlcNAc Transferase Enables Unexpected Metabolic Engineering of Cytoplasmic Proteins with 2-Azido-2-deoxy-glucose.
    Shen DL; Liu TW; Zandberg W; Clark T; Eskandari R; Alteen MG; Tan HY; Zhu Y; Cecioni S; Vocadlo D
    ACS Chem Biol; 2017 Jan; 12(1):206-213. PubMed ID: 27935279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
    Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
    J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies and activity measurements for the detection of O-GlcNAc transferase and assay of its substrate, UDP-GlcNAc.
    Lefebvre T; Drougat L; Olivier-Van Stichelen S; Michalski JC; Vercoutter-Edouart AS
    Methods Mol Biol; 2013; 1022():147-59. PubMed ID: 23765660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Quantum Dot-Based Nanosensor for Sensitive Detection of O-GlcNAc Transferase Activity.
    Hu J; Li Y; Li Y; Tang B; Zhang CY
    Anal Chem; 2017 Dec; 89(23):12992-12999. PubMed ID: 29115822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
    Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
    Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thio-Linked UDP-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
    Rafie K; Gorelik A; Trapannone R; Borodkin VS; van Aalten DMF
    Bioconjug Chem; 2018 Jun; 29(6):1834-1840. PubMed ID: 29723473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of two non-UDP-mimic inhibitors of O-GlcNAc transferase by screening a DNA-encoded library.
    Balsollier C; Bijkerk S; de Smit A; van Eekelen K; Bozovičar K; Husstege D; Tomašič T; Anderluh M; Pieters RJ
    Bioorg Chem; 2024 Jun; 147():107321. PubMed ID: 38604018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity Based High-Throughput Screening for Novel O-GlcNAc Transferase Substrates Using a Dynamic Peptide Microarray.
    Shi J; Sharif S; Ruijtenbeek R; Pieters RJ
    PLoS One; 2016; 11(3):e0151085. PubMed ID: 26960196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive assay of O-GlcNAc transferase using capillary electrophoresis-laser induced fluorescence.
    Liu J; Li M; Liu X; Huang J; Yang L
    Electrophoresis; 2023 Jan; 44(1-2):53-61. PubMed ID: 35871308
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Su C; Schwarz TL
    J Neurosci; 2017 Feb; 37(8):2125-2136. PubMed ID: 28115479
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure of human O-GlcNAc transferase and its complex with a peptide substrate.
    Lazarus MB; Nam Y; Jiang J; Sliz P; Walker S
    Nature; 2011 Jan; 469(7331):564-7. PubMed ID: 21240259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.